Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in Veterans

Summary

After initial eligibility screening, Veterans who use both cannabis and tobacco will be randomly assigned to receive either varenicline (Chantix) or placebo for 12 weeks. Participants will attend weekly visits, in person or remotely, to provide breath and urine samples for testing, fill out questionnaires, and meet with study staff about medication compliance.

Timeline

Start

2023-04-17

Primary completion

2024-07-17

Completion

2024-07-17

Outcome

Outcome not reported

Stopped (Enrollment): “Despite the numerous approaches below, we have not been successful in identifying a recruitment pathway that would ensure feasibility of study continuation. We have had multiple meetings with CSR\&D leadership to discuss our study progress”

Drugs

Indications